Gilead Sciences Market Cap

Gilead Sciences has a market cap or net worth of $166.9 billion as of May 29, 2026. Its market cap has increased by 36.38% in one year.

Market Cap

166.90B

Enterprise Value

178.28B

1-Year Change

36.38%

Ranking

#93

Market Cap Chart

Since December 1, 1998, Gilead Sciences's market cap has increased from $973.10M to $166.90B, an increase of 17,051.81%. That is a compound annual growth rate of 20.56%.

Market Cap History

Date	Market Cap	% Change
May 29, 2026	166.90B	9.60%
Dec 31, 2025	152.28B	32.28%
Dec 31, 2024	115.12B	14.04%
Dec 29, 2023	100.94B	-6.25%
Dec 30, 2022	107.68B	18.22%
Dec 31, 2021	91.08B	24.72%
Dec 31, 2020	73.03B	-11.17%
Dec 31, 2019	82.21B	1.60%
Dec 31, 2018	80.92B	-13.53%
Dec 29, 2017	93.58B	-0.81%
Dec 30, 2016	94.34B	-35.31%
Dec 31, 2015	145.83B	2.55%
Dec 31, 2014	142.21B	23.49%
Dec 31, 2013	115.15B	106.93%
Dec 31, 2012	55.65B	81.01%
Dec 30, 2011	30.74B	4.49%
Dec 31, 2010	29.42B	-24.44%
Dec 31, 2009	38.94B	-16.37%
Dec 31, 2008	46.56B	8.73%
Dec 31, 2007	42.82B	43.43%
Dec 29, 2006	29.86B	24.03%
Dec 30, 2005	24.07B	58.92%
Dec 31, 2004	15.15B	28.36%
Dec 31, 2003	11.80B	76.49%
Dec 31, 2002	6.69B	6.07%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Johnson & Johnson	542.42B
AbbVie	384.67B
Merck & Co.	293.22B
AstraZeneca	288.46B
Novartis AG	287.62B
Novo Nordisk	202.87B
Amgen	181.77B
Pfizer	149.21B

Market Cap Rankings